+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?



Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?



Cardiovascular Research 67(1): 11-20



Atherosclerosis is considered to be a form of chronic inflammation governed by a complex network of inter- and intra-cellular signaling pathways. The pleiotropic cytokine interferon-gamma (IFN-gamma) is a key pro-inflammatory mediator that is expressed at high levels in atherosclerotic lesions. IFN-gamma regulates the function and properties of all the cell types in the vessel wall. The precise role of IFN-gamma in atherogenesis is complex, with both pro- and anti-atherogenic actions being identified. This review will discuss these actions of the cytokine along with recent findings that have emerged from mouse models of atherosclerosis that are deficient in IFN-gamma signaling.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049376658

Download citation: RISBibTeXText

PMID: 15907820

DOI: 10.1016/j.cardiores.2005.04.019


Related references

A new mass spectrometric carboxyl terminal sequencing technique finds a similarity between gamma interferon and alpha 2 interferon and identifies a proteolytically clipped gamma interferon that retains full anti viral activity. Biochemical Journal 215(2): 273-278, 1983

Anti-inflammatory and anti-atherogenic role of BMP receptor II in atherosclerosis. Future Cardiology 9(5): 619-622, 2013

Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. Cardiovascular Research 94(3): 428-438, 2012

In vivo effects of interferon-gamma and anti-interferon-gamma antibody on the experimentally induced lichenoid tissue reaction. British Journal of Dermatology 119(2): 199-206, 1988

Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice. Experimental Neurology 172(2): 460-468, 2001

Cytokines and anti-cytokine autoantibodies during experimental african trypanosomiasis in mice with disrupted interferon-gamma and interferon-gamma receptor genes. International Journal of Molecular Medicine 1(1): 177-183, 1998

Postnatal anti-interferon-gamma treatment prevents pancreatic inflammation in transgenic mice with beta-cell expression of interferon-gamma. Journal of Interferon Research 14(3): 111-116, 1994

Anti-interferon-gamma antibodies in a patient undergoing interferon-gamma treatment for systemic mastocytosis. Journal of Interferon & Cytokine Research 16(7): 519-522, 1996

Anti-atherogenic effect of NIP-200 on the experimental atherosclerosis in cholesterol-fed rabbits. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 99(1): 37-43, 1992

Serum anti-elastase activity in atherosclerosis and atherogenic disease. Giorn Gerontol 11(4): 307-318, 1963

The anti-atherogenic action of cortisone and methylandrostenediol in experimental atherosclerosis in rabbits. Farmakol I Toksikol 27(1): 32-35, 1964

On the Anti-Atherogenic Activity of Cortisone and Methylandrostendiol in Experimental Atherosclerosis in Rabbits. Farmakologiia i Toksikologiia 27: 32-35, 1964

Anti-atherogenic effect of 15-lipoxygenase overexpression in rabbit atherosclerosis models. Prostaglandins & Other Lipid Mediators 59(1-6): 145, 1999

Effect of anti interferon gamma ifn gamma and anti il 2 monoclonal antibodies in sjl j mice with experimental allergic encephalomyelitis eae. FASEB Journal 5(6): A1780, 1991

Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease. Clinical Immunology and Immunopathology 63(1): 66-73, 1992